| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 264 |
| 1 | RITUXIMAB | 259 |
| 2 | TACROLIMUS | 245 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 235 |
| 4 | TACROLIMUS OINTMENT 0.1% | 235 |
| 5 | MYCOPHENOLATE MOFETIL | 219 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 219 |
| 7 | PREDNISOLONE | 174 |
| 8 | PREDNISOLONE ORAL | 174 |
| 9 | PREDNISOLONE ORAL SOLUTION | 174 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 31 | 0.0888 |
| 1 | NICOTINAMIDE | 31 | 0.0121 |
| 2 | TERLIPRESSIN | 4 | 0.0121 |
| 3 | HYDRALAZINE HYDROCHLORIDE | 27 | 0.0101 |
| 4 | CIDOFOVIR ANHYDROUS | 14 | 0.0097 |
| 5 | CLINDAMYCIN PALMITATE HYDROCHLORIDE | 2 | 0.0088 |
| 6 | DEFEROXAMINE MESYLATE | 18 | 0.0083 |
| 7 | TREOSULFAN | 21 | 0.0076 |
| 8 | MEGNESIUM OXIDE | 3 | 0.0072 |
| 9 | CLINDAMYCIN PHOSPHATE | 36 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 604 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 270 |
| 2 | Alkylating Drug [EPC] | 195 |
| 3 | Kinase Inhibitor [EPC] | 143 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 117 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 99 |
| 6 | Azole Antifungal [EPC] | 96 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 76 |
| 8 | mTOR Inhibitor Immunosuppressant [EPC] | 60 |
| 9 | Antiprotozoal [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 4 | 0.0121 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 13 | 0.0053 |
| 2 | Antiprotozoal [EPC] | 56 | 0.0053 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 14 | 0.0043 |
| 4 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 15 | 0.0026 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 55 | 0.0025 |
| 7 | Antimalarial [EPC] | 25 | 0.0024 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 27 | 0.0016 |
| 9 | Vitamin D3 Analog [EPC] | 32 | 0.0016 |